History

• 2014

  Carbiotix was founded in 2014 based on four years of research at the Department of Biotechnology at Lund University and the Antidiabetic Food Centre (AFC) in Lund, Sweden.

• 2015

  In 2015, the company’s second-generation soluble fiber CarbiAXOS was selected as a top new ingredient by the Nutrition Capital Network in both Europe and the U.S.

• 2016

  In 2016, the company continued with the commercialisation of CarbiAXOS working in collaboration with industry leading partners across the supply chain.

• 2017

  In 2017, Carbiotix began development of its low-cost microbiome testing platform. The mission was to deliver an affordable low-cost microbiome test to consumers without cutting corners on quality.

• 2018

  In 2018, Carbiotix launched the LinkGut platform where customers could gain an accurate and informative overview of their gut health. During 2018, Carbiotix also commenced a 300-person gut health study to validate the LinkGut platform and a strategy to explore medical foods and therapeutics across multiple disease areas.

• 2019

  In 2019, the company began to leverage data from its low-cost microbiome testing platform to ramp up modulator development activities. These activities were in line with its long-term strategy to create microbiome modulators based on its proprietary soluble CarbiAXOS fiber, isolated strains, and novel delivery mechanisms.

• 2020

  In 2020, the Carbiotix laid out its strategy regarding modulators, with an initial focus on bringing to market CarbiAXOS. Carbiotix also communicated that it will focus on business to business services within the microbiome diagnostics area as a means to build relationships with modulator customers and advocates.

• 2021

  At the beginning of 2021, the company shifted its LinkGut service to solely an API service. This would allow the company to move away from data interpretation and focus on the logistics of offering a compelling microbiome test that is cost effective, reliable and flexible.

• 2022

  In June of 2022, Carbiotix opened it's first CarbiAXOS production site in Bjuv, Sweden.

• 2023

  Carbiotix develops news CarbiAXOS process that doubles yields, signs collaboration agreements with leading functional food and probiotics companies, doubles number of LinkGut customers, reports promising results from CarbiAXOS Metformin study, achieves regulatory approval for CarbiAXOS cosmetic ingredient and completes phase one of production site upgrade.

• 2024

  Carbiotix receives GRAS regulatory approval for CarbiAXOS, achieves IVDR and CE marked status for LinkGut testing kit, launches NutraCycle upcycling service for plant-based food and beverage manufacturers, receives first clinical and animal related LinkGut orders, and rebrands CarbiAXOS to Carbersol.